|
Targeting asthma, food allergies and more, Allakos bumps up Series A to $42M
San Francisco Business Times (blog) The San Mateo company, founded by veterans of KaloBios Pharmaceuticals Inc., is developing antibody-based drugs against inflammatory diseases, such as asthma, food allergies and gastrointestinal conditions. It is zeroing in on so-called T-helper cells, … |
View full post on asthma – Google News